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Abstract
Background: Keratins are cytoplasmic intermediate filament proteins expressed in tissue specific and differentiation
dependent manner. Keratins 8 and 18 (K8 and K18) are predominantly expressed in simple epithelial tissues and perform
both mechanical and regulatory functions. Aberrant expression of K8 and K18 is associated with neoplastic progression,
invasion and poor prognosis in human oral squamous cell carcinomas (OSCCs). K8 and K18 undergo several post-
translational modifications including phosphorylation, which are known to regulate their functions in various cellular
processes. Although, K8 and K18 phosphorylation is known to regulate cell cycle, cell growth and apoptosis, its significance
in cell migration and/or neoplastic progression is largely unknown. In the present study we have investigated the role of K8
phosphorylation in cell migration and/or neoplastic progression in OSCC.
Methodology and Principal Findings: To understand the role of K8 phosphorylation in neoplastic progression of OSCC,
shRNA-resistant K8 phospho-mutants of Ser73 and Ser431 were overexpressed in K8-knockdown human AW13516 cells
(derived from SCC of tongue; generated previously). Wound healing assays and tumor growth in NOD-SCID mice were
performed to analyze the cell motility and tumorigenicity respectively in overexpressed clones. The overexpressed K8
phospho-mutants clones showed significant increase in cell migration and tumorigenicity as compared with K8 wild type
clones. Furthermore, loss of K8 Ser73 and Ser431 phosphorylation was also observed in human OSCC tissues analyzed by
immunohistochemistry, where their dephosphorylation significantly correlated with size, lymph node metastasis and stage
of the tumor.
Conclusion and Significance: Our results provide first evidence of a potential role of K8 phosphorylation in cell migration
and/or tumorigenicity in OSCC. Moreover, correlation studies of K8 dephosphorylation with clinico-pathological parameters
of OSCC patients also suggest its possible use in prognostication of human OSCC.
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Introduction
Keratins (K) are largest subgroup of intermediate filament (IF)
proteins preferentially expressed in epithelial tissues [1,2]. They
are subdivided into type I acidic (K9–K28) and type II basic (K1–
K8 and K71–K74) keratins [2,3] on the basis of their biochemical
properties such as molecular weight and isoelectric point [4].
They are obligatory heteropolymers and are assembled in 1:1
molar ratio, consisting of one type I and one type II keratins
[1,2,5]. Epithelial tissues express different pairs of keratins
depending on the cell type e.g. all stratified squamous epithelia
express K5 and K14 [6] while K8 and K18 are seen in all simple
epithelia [7].
K8 and K18 is the prototype keratin pair of simple epithelia
and are predominantly expressed in epithelial components of
glandular tissues, including the pancreas and intestine, with other
keratins such as K7, K19 and K20 [8]. Apart from their known
protective mechanical functions, K8 and K18 also execute
various regulatory functions, which include modulation of protein
localization, protein targeting/trafficking and protein synthesis
[7,9].
K8 and K18 expression is not observed in stratified adult
epithelial tissues. However, they are often aberrantly expressed in
carcinomas including oral SCC and their expression is correlated
with invasion and poor prognosis [2,10,11]. Aberrant overexpres-
sion of K8 and K18 in SCC cell lines has been shown to promote
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has shown that K8 overexpression leads to neoplastic transforma-
tion and increased invasive and metastatic potential in FBM cell
line [12]. These observations were further supported by a
transgenic study [13]. Recently, we have shown that K8
knockdown leads to reduction in cell migration and tumorigenicity
accompanied with downregulation of b4-integrin-mediated sig-
nalling in OSCC cells [14].
All IF proteins, including keratins, consist of a conserved central
coiled-coil a-helical- ‘‘rod’’ domain and flanking non–a-helical
NH2-terminal ‘‘head’’ and COOH-terminal ‘‘tail’’ domains
[5,15]. Their post translational modifications including phosphor-
ylation reside in flanking head and tail domains [16]. Keratin
phosphorylation is dynamic process which affects the organization
of filaments, either by increasing the exchange between the soluble
and the cytoskeletal fraction or by regulating the binding sites of
associated proteins e.g. 14-3-3 [16,17]. It is also involved in the
regulation of many protein functions which include protection
against stress, signaling, apoptosis and cell compartment-specific
roles [16,17]. Most of the phosphorylation sites identified so far
involve distinct serine (Ser) residues of keratins [16]. Several
protein kinases, such as PKC, p38, ERK, cAMP and JNK are
known to phosphorylate keratins [16,17,18]. Prior studies show
that exposure of cells or tissues to phosphatase inhibitors causes
dramatic hyperphosphorylation of K8 and K18 [19,20,21,22].
Recently, specific phosphatases such as phosphatase of regener-
ating liver-3 (PRL-3) and protein phosphatase-2A (PP2A) have
been identified which dephosphorylate K8 at specific residue
[23,24]. Hyperphosphorylation of K8 and K18 is observed under
conditions of tissue injury, stress and apoptosis [17,25]. Ser23,
Ser73 and Ser431 are the three phosphorylation sites of K8 [16].
Phosphorylation of K8 at residue Ser431 observed in response to
epidermal growth factor (EGF) stimulation [26]. Ser73 is
phosphorylated in response to various types of cellular stresses
[18]. A recent report suggests that K8 Ser73 and Ser431
dephosphorylation is associated with cell migration and metastasis
in colorectal cancer [23]. However, the significance of K8
phosphorylation in neoplastic progression of SCC is not yet
studied.
In the present study we have shown that overexpression of
shRNA-resistant K8 phospho-mutants in K8-knockdown OSCC
cells demonstrate increase in cell motility and tumorigenicity
compared with K8-wild type clone. Furthermore, K8 dephos-
phorylation was also observed in human OSCC samples which
significantly correlated with size, lymph node metastasis and stage
of the tumor.
Results
Generation of shRNA-resistant K8-phospho-mutants and
K8 wild type constructs
In order to express K8 phpspho-mutants and K8-wild type in
K8 knockdown AW13516 cells, shRNAK8.2 resistant GFP tagged
K8 phospho-mutants and K8-wild type (described above) were
generated by site directed mutagenesis. The resistance of resulted
mutants against shRNAK8.2 was checked by cotransfecting them
with shRNAK8.2 in HEK-293 cells followed by measurement of
fluorescence intensity and western blot analysis (detail strategy of
generation of these constructs has been described as flow chart in
Figure 1A). The GFP tagged K8-Ser73Ala phospho-mutant (K8-
S73A-GFP-R) and K8-Ser431Ala phospho-mutant (K8-S431A-
GFP-R) constructs were found to be resistant to shRNAK8.2
(Figure 1C-F).
Overexpression of K8-phospho-mutants in K8-
knockdown AW13516 cells
In order to investigate the role of individual K8 phosphorylation
(Ser73 and Ser431) during tumor progression in OSCC, shRNA-
resistant K8-Ser73Ala and K8-Ser431Ala phospho-mutants were
transfected in K8 deficient AW13516 C1-shRNAK8.2 cells. Stably
over-expressed GFP tagged K8 wild type (K8WT-1and -2), K8-
Ser73Ala mutant (K8S73A-1 and -2) and K8- Ser431Ala mutant
(K8S431A-1 and -2) clones were selected in 1000 ug/ml G418-
sulphate (detail strategy of generation of the K8-phospsho-mutant
clones has been described as flow chart in Figure 1B). The over-
expression of exogenous GFP-tagged K8 in stable clones (K8WT-
1 and -2; K8S73A-1 and -2; K8S431A-1 and -2) was analyzed by
western blot and RT-PCR analysis. All the clones showed
considerable overexpression of exogenous K8 (Figure 2A, B).
Western blot analysis using antibody specific to phosphorylated
Ser73 or Ser431 of K8 confirmed the reduction of K8 phos-
phorylation on respective site in the phospho-mutant overex-
pressed clones (Figure 3A, B). Further, we also observed increase
in K18 levels in these over-expressed clones by western blot
analysis (Figure 2A). In addition, the filament formation by
exogenously expressed GFP tagged K8 was analyzed by confocal
microscopy. All the K8 wild type and phospho-mutant clones
formed proper filaments with endogenous K18 (Figure 2B, 3C).
There was no considerable difference in filament organization
observed in the cells expressing K8 phospho-mutants compared
with the cells expressing wild type K8. In addition, we have also
observed considerable increase in K18 levels in both phospho-
mutants and wild type stable clones (Figure 3A, B).
Loss of K8 phosphorylation leads to increase in cell
migration
Several prior studies demonstrated the role of keratin filaments
in cell migration and wound healing [27]. During cell migration,
keratin filaments undergo reorganization and their phosphoryla-
tion has been shown to regulate filament organization during
various patho-physiological conditions [16,17]. In order to
determine the effect of loss of K8 phosphorylation on migratory
behavior of the cells, first distribution of GFP-tagged exogenous
K8 was analyzed by inverted fluorescence microscopy (Axio
Vision 2000, Zeiss). The highly expressing GFP-tagged K8-
Ser73Ala phospho-mutant and K8-Ser431Ala phospho-mutant
cells were found to be on the edge of the colonies, while the GFP
tagged K8 wild type expressing cells were uniformly distributed
throughout the colonies (Figure 4A). These results suggested that
loss of phosphorylation may lead to increase in migratory ability of
the cells. Further, to confirm the effect of loss of K8 phos-
phorylation on cell migration, wound healing assay was per-
formed. The stable K8-Ser73Ala and K8-Ser431Ala mutant
clones demonstrated significant increase in cell migration com-
pared to wild type clone (Figure 4B). These results together
indicated that loss of K8 phosphorylation at Ser73 and Ser431
leads to increase in migratory ability of the OSCC derived cells.
Loss of K8 phosphorylation resulted in increased
tumorigenicity
K8 and K18 are often aberrantly expressed in OSCC and their
expression correlates with invasion and poor prognosis [10,28]. K8
and K18 have been shown to promote tumorigenicity and
migration in carcinoma cells including cell lines derived from
OSCC [12,14,29]. In order to find out the role of K8 dephos-
phorylation on tumorigenic potential of OSCC cells, K8-Ser73Ala
mutant (K8S73A-1 and -2), K8- Ser431Ala mutant (K8S431A-1
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sub-cutaneously in NOD-SCID mice. In mice injected with K8
phospho-mutant clones the volume of tumor formation was
significantly higher as compared to mice injected with K8 wild
type clones (Figure 5A, B). To confirm the loss of K8
phosphorylation, these tumors were dissected and further analyzed
for phosphorylation of Ser73 and Ser431 residue of K8 using
immunohistochemistry. The tumors obtained from the K8 wild
type clones showed staining of GFP and phosphorylated Ser73 and
Ser431 residues of K8. The tumors developed from the K8-
Ser73Ala and K8-Ser431Ala phospho-mutants did not show
staining for phosphorylated K8 with respective antibodies
Figure 1. Generation of RNAi resistant K8 phospho-mutants constructs.( A) Strategy for generation of shRNA resistant K8 wild type and K8
phospho-mutants, Ser73Ala and Ser431Ala constructs. (B) Strategy for generation of K8 wild type and K8 phospho-mutants, Ser73Ala and Ser431Ala
stable clones in K8-knockdown AW13516 cells. (C and D) Mutated RNAi resistant GFP-tagged K8 phospho-mutants, K8-S73A-GFP-R and K8-S431A-
GFP-R were validated by cotransfecting them with shRNAK8.2 or vector pTU6-PURO in HEK293 cells. shRNA-sensitive GFP-tagged phospho-mutants
(K8-S73A-GFP and K8-S431A-GFP) were also transfected separately in HEK293 cells and used as controls. Representative images of GFP expression
60 hrs of post-transfection (combination of transfection is indicated in figure; Magnification 10X). (E and F) Western blot analysis of proteins
extracted from cells transfected with shRNA-resistant (K8-S73A-GFP-R and K8-S431A-GFP-R) and their respective shRNA-sensitive constructs (K8-S73-
GFP and K8-S431-GFP) using K8 antibody (order of samples is indicated in figure). b-actin was used as loading control.
doi:10.1371/journal.pone.0027767.g001
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Ser73 and Ser431 phosphorylation leads to increase in tumorige-
nicity of the OSCC cells.
Loss of K8 phosphorylation in human OSCC tissues
In order to confirm the results of in vitro study, the levels of
phosphorylated K8 were analyzed in human OSCC. A total of 52
human OSCC samples were analyzed for levels and localization of
phosphorylated K8 (Ser73 or Ser431) using semi-quantitative IHC
analysis (supplementary material; Figure S1). None of the non-
malignant samples which were used as controls showed positive
staining of K8 (supplementary material; Figure S2). All the tumor
samples used in this study were K8 positive (supplementary
material; Figure S2). 46% of these OSCC samples showed
negative staining with phospho-K8Ser73 antibody while 58% of
OSCC demonstrated negative staining with phospho-K8Ser431
antibody (Figure 6A). Thus many of human OSCC samples
showed loss of K8 phosphorylation at both Ser73 and Ser431.
Correlation of K8 dephosphorylation with clinico-
pathological parameters of the patients
To evaluate the clinical significance of K8 dephosphorylation in
OSCC, we investigated the correlation between levels of K8
phosphorylation at Ser73 and Ser431 residue with clinico-
pathological parameters of the patients using Chi Square test. Loss
of K8phosphorylationat residue Ser73 of samples showinghigh K8
expression significantly correlated with tumor size (P=0.002),
lymph node metastasis (P=0.011) and stage (P=0.013) (Table 1:
Figure 6B). K8 dephosphorylation at residue Ser431 of samples
showing high K8 expression demonstrated statistically significant
correlation with tumor size (P=0.002), and stage (P=0.009)
(Table 1; Figure 6B). K8 dephosphorylation at residue Ser431 also
showed border line significance with lymph node metastasis
(Table 1; Figure 6B). Status of K8 phosphorylation did not show
any correlation with other parameters. Kaplan–Meier survival
analysis was conducted to establish correlation between K8
dephosphorylation and patient survival. Overall dephosphorylation
Figure 2. Stable overexpression of GFP-tagged K8 phospo-mutants in K8 knockdown AW13516 cells. (A) Western blot analysis of stable
overexpressed K8 wild type (K8WT-1 and -2), K8-Ser73Ala phospho-mutant (K8S73A-1 and -2), K8-Ser431Ala phospho-mutant (K8S431A-1 and -2) and
pEGFP (pEGFP-1 and -2) clones derived from K8 knockdown cells with antibodies to K8 and K18. b-actin was used as loading control. (B) RT-PCR
analysis of K8 in stable K8 wild type and phospho-mutant clones. GAPDH was used as internal control. (C) Representative confocal images of
filaments formed by GFP-tagged K8 in stable K8WT-1, KS73A-1 and K8S431A-2 clones. pEGFP-N3 empty vector transfected (pEGFP-1) clone was taken
as control. Scale bar: 50 mm.
doi:10.1371/journal.pone.0027767.g002
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survival (Figure 6C; P=0.047), while phosphorylationat Ser431 did
not correlate with patient survival (Figure 6D). Thus, our IHC
analysis of tumor tissues indicated the correlation of K8
dephosphorylation with bad prognosis in OSCC patients.
In summary, overexpression of K8 Ser73Ala and Ser431Ala
mutants in K8-knockdown OSCC cells resulted in significantly
increased cell migration and tumorigenicity. Furthermore, our in
vitro results correlated well with IHC analysis of OSCC samples.
Dephosphorylation of K8 (both at Ser73 and Ser431) was
Figure 3. Analysis of K8 phosphorylation at Ser73 and Ser431 and their filament formation with K18 in stable K8 phospho-mutant
clones. (A and B) Western blot analysis of stable overexpressed K8 wild type (K8WT-1 and -2), K8 Ser73Ala phospho-mutant (K8S73A-1 and -2) and
K8 Ser431Ala phospho-mutant (K8S431A-1,-2 and -3) clones with antibodies against K8 or phospho-specific K8 Ser73 or Ser431. K8-knockdown
(shRNAK8.2-C1) and vector control (pTU6-Cont) clone were taken as controls. b-actin was used to ensure equal loading. (C) Representative confocal
micrographs of filaments formed by GFP-tagged K8 with endogenous K18 in K8 wild type (K8WT-1), K8Ser73Ala (K8S73A-1) and K8Ser431Ala
(K8S431A-2) clones. Stably overexpressed empty vector clone (pEGFP-1) was taken as control. Scale bar: 50 mm.
doi:10.1371/journal.pone.0027767.g003
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PLoS ONE | www.plosone.org 5 November 2011 | Volume 6 | Issue 11 | e27767Figure 4. Effect of decreased K8 Ser 73 or Ser431 phosphorylation on migratory ability of OSCC cells. (A) Representative fluorescence
and phase contrast micrographs of K8 wild type (K8WT-1) and K8 phospho-mutants (K8S73A-1 or K8S431A-2) cells that displayed GFP-tagged K8
analyzed by fluorescence microscopy. Note that the cells expressing high levels of K8-Ser73Ala or K8-Ser431Ala mutant appeared on the edges of the
colony. Scale bar: 50 mm. (B) Scratch wound healing assays were performed on K8 wild type (K8WT-1), K8-Ser73Ala (K8S73A-1) and K8-Ser431Ala
(K8S431A-2) clones. Phase contrast images (10X) of wound closure at 0 hr (panels a–c), 2.5 hr (panels d–f), 5 hr (panels g–i), 7.5 hr (panels j–l), and
10 hr (panels m–o) of the clones are shown in the figure. Scale bar: 100 mm. Migration rate was calculated by AxioVision software. The data shown is
the average from three independent experiments with the mean and standard deviation. *P,0.05, ** P,0.01 (by student t-test).
doi:10.1371/journal.pone.0027767.g004
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PLoS ONE | www.plosone.org 6 November 2011 | Volume 6 | Issue 11 | e27767Figure 5. Loss of K8 phosphorylation resulted in increased tumorigenicity of AW13516 cells. (A)1 0
3 cells from K8 wild type (K8WT-1 and
-2), K8 Ser73Ala phospho-mutant (K8S73A-1 and -2) and K8 Ser431Ala phospho-mutant (K8S431A-1 and -2) clones were injected subcutaneously into
6 different NOD-SCID mice and tumor volume measured as described. Representative images of SCID mice bearing tumors of K8WT-1, K8S73A-1 and
K8S431A-2 clone 60 days after the injection. Scale bar: 10 mm (B) Bars, mean value and SD of tumor volume of K8 wild type (K8WT-1 and -2), K8-
Ser73Ala (K8S73A-1 and -2) and K8-Ser431Ala (K8S431A-1 and -2) mutant after 60 days is plotted. Statistical analysis was done by Student’s t test.
*P,0.05; **P,0.01. (C) Representative images of immunohistochemical staining (with antibodies against GFP, K8-phospho-Ser73 and K8-phospho-
Ser431 as indicated) of tumor tissues obtained from NOD-SCID mice injected with K8WT-1, K8S73A-1 or K8S431A-2 clones. TBS was used as a control
(Magnification: 200X). Note that K8S73A-1 and K8S431A-2 clone showed loss of K8 phosphorylation at Ser73 and Ser431 respectively.
doi:10.1371/journal.pone.0027767.g005
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(both at Ser73 and Ser431) correlated with tumor size, lymph node
metastasis and stage. Moreover, dephosphorylation of K8 at residue
Ser73 significantly correlated with poor patient survival.
Discussion
IF form an important tissue specific compartment of cellular
cytoskeleton [5]. Alterations in cellular IF expression occur as a
key feature during the progression/transition from the benign to
the malignant phenotype in several tumor types including OSCC
[29,30]. Although previous reports have highlighted importance of
K8 and K18 expression in prognosis and progression of SCC
[11,14,31], significance of their posttranslational modifications
such as phosphorylation is not been investigated yet. In the present
study, we have investigated the role of K8 phosphorylation in
tumor cell migration and progression of OSCC and further tried
to understand the correlation of levels of K8 phosphorylation in
human OSCC tissue samples with clinico-pathological parameters
of the patients.
We have used an OSCC derived cell line AW13516 as model
system in this study [32]. These cells express high amount of K8
and K18 and form proper filaments. Previously, we have
knockdown K8 levels using shRNA specifically targeting K8 in
these cells [14]. Here, we have replaced endogenous wild type K8
with phospho-mutants, Ser73Ala and Ser431Ala of K8 by
transfecting respective shRNA resistant K8-phospho mutant
constructs (Figure 1 and 2). K8 knockdown background nullified
the effect of phosphorylation of endogenous K8 and allowed us to
compare the phenotype of wild type with phospho-mutants of K8.
The stable clones expressing K8 phospho-mutants, Ser73Ala and
Ser431Ala showed substantial reduction in phosphorylation of
respective sites (Figure 3A, B). These phospho-mutant clones did
not show significant difference in K8 and K18 filament formation
compared to wild type K8 expressing OSCC cells (Figure 3C).
Keratin phosphorylation is a highly dynamic process that plays an
important role in regulating keratin filament organization as
established from studies involving cultured cells and transgenic
mouse models [16]. It appears that loss of phosphorylation at these
sites may affect the dynamics of their filament assembly rather
than their formation in these cells.
Dynamics of K8 and K18 filament assembly is controlled by
their post translational modifications mostly by phosphorylation
under various patho-physiological conditions [16,17]. These
Figure 6. IHC analysis of K8 phosphorylation in human OSCC. (A) Levels of K8 phosphorylation at Ser73 and Ser431 in K8 positive paraffin
embedded section of human OSCC samples were determined by immunohistochemical (IHC) analysis. Representative images of IHC staining with site
specific phospho-antibodies against K8Ser73, K8Ser431 and total K8. (Magnification: 200X). (B) Histograms showing correlations of K8
dephosphorylation at Ser73 and Ser431 with clinico-pathological parameters such as tumor size, lymph-node metastasis and tumor stage of
human OSCC patients. (C and D) Kaplan–Meier analysis of overall survival in OSCC patients and loss of K8 phosphorylation at Ser73 or Ser 431
residue (for K8 Ser73 phosphorylation * P=0.047).
doi:10.1371/journal.pone.0027767.g006
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determinants of the altered migratory behaviour of the cell [27]. In
the present study, K8 phospho-mutants both Ser73Ala and
Ser431Ala showed significant increase in cell migratory ability
compared to K8-wild type clone. Results of our fluorescence
microscopy analysis showed that, cells showing high expression of
K8-phospho-mutants appeared on the edge of the colonies. This
indicated possible increase in their migratory ability (Figure 4A).
We confirmed the increase in cell migration using wound healing
assay (Figure 4B). Prior studies have shown that K8 and K18
regulate cell migration in various cell types including OSCC
[14,33,34]. Mizuuchi et al. have demonstrated correlation of PRL-
3 dependent K8 dephosphorylation at Ser73 and Ser431 with
increased cell motility in colorectal cancer derived-cells. They have
also demonstrated the localization of K8 at cellular lamellipodias
and ruffles in vivo [23]. Our data are in agreement with their
findings and provide direct evidence for regulation of cell motility
by K8 phosphorylation in carcinomas.
Progression of tumor cells is dependent on their migratory
ability [35]. Our results of in vivo tumorigenicity assay
demonstrated that loss of K8-phosphorylation (both Ser73 and
Ser431) led to significant increase in tumor volume compared to
K8 wild type expressing cells (Figure 5). In our previous study, we
have shown reduction in tumorigenicity in response to K8
knockdown in OSCC cells [14]. We have also demonstrated that
K8 and K18 filament formation promotes neoplastic transforma-
tion in oral epithelia derived cells [12]. These results together
suggest that loss of K8 phosphorylation at Ser73 and Ser431
enhances tumor growth of the OSCC cells in vivo.
Next, to understand the prognostic significance of K8
dephosphorylation in human OSCC, we studied correlation of
K8 dephosphorylation with clinico-pathological parameters of the
patients. Here we observed loss of K8 phosphorylation at both
Ser73 and Ser431 in K8 positive OSCC samples (Figure 6A;
Table 1). Loss of K8 Ser73 or Ser431 phosphorylation showed
statistically significant correlation with tumor size (Table 1;
Figure 6B). Larger tumor size is associated with an increased risk
of local recurrence, increased lymph node metastasis and poor
patient survival in OSCC [36]. Loss of K8 phosphorylation also
significantly correlated with tumor stage (Table 1; Figure 6B). A
large number of studies have demonstrated that disease staging has
a crucial influence on the outcome [37,38]. Furthermore,
dephosphorylation at Ser73 of K8 showed statistically significant
correlation with lymph node metastasis while Ser431 dephosphor-
ylation demonstrated border line significance with lymph node
metastasis (Table 1; Figure 6B). Lymph node metastasis is widely
accepted as one of the major prognostic factors and is associated
with a decrease in overall survival and higher recurrence rates in
patients with OSCC [39,40,41,42]. These results are consistent
with previous data on colorectal tumor tissue, which demonstrated
loss of K8 phosphorylation at Ser73 and Ser431 residues, at the
invasive front and in the liver metastases [23]. Moreover, loss of
K8 phosphorylation at Ser73 also significantly correlated with
poor survival of OSCC patients (Figure 6C). We did not observe
significant correlation of K8 Ser431 dephosphorylation with
patient survival probably because of smaller sample size. Thus
our results indicate possible prognostic value of K8 dephosphor-
ylation in OSCC. A study with larger sample size is required to
unequivocally prove the prognostic significance of K8 dephos-
phorylation in OSCC.
Prior studies suggest that keratin phosphorylation is regulated in
vivo by many kinases and phosphatases during various patho-
physiological conditions [17]. Previously, Tao et al, have identified
a phosphatase, PP2A which dephosphorylates K8 specifically at
residue Ser431 under hyposmotic condition in cell culture system.
Interestingly, PP2A regulates K8 phosphorylation in colonic
cancer derived cell line and not in their normal counterpart
[24]. Recently, Mizuuchi et al. have shown that, inhibition of
Table 1. Correlations of K8 dephosphorylation (Ser73 and Ser431) with clinico-pathological parameters of the OSCC patients
(n=52).
Clinico-pathological parameter n Keratin 8 (K8) and pS73 Keratin 8 (K8) and pS431
K8(High)
pS73(2)
(n=9)
K8(High)
pS73(+)
(n=13)
K8(Low)
pS73(2/+)
(n=30) P-value
K8(High)
pS431(2)
(n=5)
K8(High)
pS431(+)
(n=16)
K8(Low)
pS431(2/+)
(n=31) P-value
Age (Years) ,50 30 4 8 18 0.673 3 9 18 0.987
$50 2 2 551 2 27 1 3
Sex Male 40 6 12 22 0.289 2 14 23 0.378
Female 1 2 318 22 8
Thickness ,2c m 40 8 10 22 0.624 4 13 23 0.850
$2c m 1 2 138 13 8
Stages I/II 1 2 101 1 0.013
# 01 1 10.009
#
III/IV 40 8 13 19 5 15 20
Tumor Size T1/T2 2 1 211 8 0.002
# 12 1 80.002
#
T3/T4 31 7 12 12 4 14 13
Lymph node
metastasis
YES 35 6 13 16 0.011* 4 14 17 0.063
NO 1 7 301 4 12 1 4
Differentiation Poor 17 3 3 11 0.683 1 5 11 0.782
Moderate 35 6 10 19 4 11 20
*- Pearson Chi-Square,
# - Spearman Correlation (Ordinal by Ordinal).
doi:10.1371/journal.pone.0027767.t001
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phosphorylation at Ser73 and Ser431 along with significant
reduction in cell migration in colorectal cells [23]. These
observations also correlated with higher PRL-3 expression and
reduced K8phosphorylationatboththesitesin tumor tissue samples
[23]. Importantly, Hassan et al. have demonstrated higher PRL-3
expression in OSCC and dysplasia compared to normal oral tissues
[43].These findings together suggestthat loss of K8 phosphorylation
may be due to higher PRL-3 activity in OSCC samples. Further
studies are necessary to establish the role of phosphatases in K8
phosphorylation dependent progression of carcinomas.
In summary, our results clearly suggest that loss of K8
phosphorylation leads to increased cell migration and tumorige-
nicity in OSCC cells. In addition, K8 dephosphorylation was also
observed in human OSCC samples which correlated with tumor
size, stage and lymph node metastasis. Furthermore, loss of K8
Ser73 phosphorylation significantly correlated with poor patient
survival indicating its significance in prognosis. Our results support
Mizuuchi et al’s hypothesis that phosphorylation dependent
reorganization of keratins accelerate cell motility and metastatic
potential of carcinomas [23]. However, the exact role K8
dephosphorylation in cell motility and tumor progression is yet
to be elucidated. Thus, the present study provides important
insights into the understanding the role of keratin phosphorylation
during tumor progression and K8 dephosphorylation shows a
good promise to be used as prognostic marker. Moreover,
intervention strategies to inhibit phosphatase mediated K8
dephosphorylation in OSCC might lead to the development of
novel therapeutic targets for invasive and metastatic carcinomas.
Materials and Methods
Ethics statement
This study was approved by the ‘‘Tata Memorial Hospital
Human Ethics Committee’’. The written informed consent was
obtained from the patients as well as healthy individuals. All
protocols for animal studies were reviewed and approved by the
‘‘Institutional Animal Ethics Committee (IAEC)’’ constituted
under the guidelines of the ‘‘Committee for the Purpose of
Control and Supervision of Experiments on Animals (CPCSEA)’’,
Government of India (Approval ID: 15/2007).
Cell lines, plasmids and site directed mutagenesis
The cell line AW13516 derived from the SCC of tongue [32]
and HEK-293 (ATCC) were cultured in IMDM and DMEM
(Gibco), respectively, supplemented with 10% fetal calf serum
(FCS; Hyclone) and antibiotics, at 37uC and under 5% CO2
atmosphere [14].
To generate shRNA resistant K8-GFP wild type (K8-GFP-WT-
R), K8-Ser73 mutant (K8-GFP-S73A-R) and K8-Ser431 mutant
(K8-GFP-S431A-R), Quick change Site directed mutagenesis kit
(Stratagene) was used (K8-phospho-mutant constructs are a kind
gift of Dr. Normand Marceau, Canada) [44]. Primer 59-GGAG-
GCATCACCGCTGTGACGGTCAACCAGAGC-39 was syn-
thesized as per manufacturer’s instructions, containing 2 silent
mutations in the shRNAK8.2 binding site [14]. The resulted
mutations were verified by direct DNA sequencing.
Transfection and selection of stable clones
To investigate the effect of K8 phosphorylation on cell
migration and tumorigenicity, the shRNA resistant K8-GFP wild
type (K8-WT-GFP-R), K8-Ser73 mutant (K8-S73A-GFP-R) and
K8-Ser431 mutant (K8-S431A-GFP-R) were overexpressed in
K8-knockdown clone shRNAK8.2-C1. The stable K8-knockdown
clones were generated as described previously [14]. Briefly, 2 mgo f
shRNAK8 construct (Target site: given in Figure 1) or the empty
vector control were transfected in AW13516 cells, by liposome-
based FuGENE HD transfection reagent (according to manufac-
turer’s protocol; Roche). The stable K8-knockdown clones were
selected in medium containing 0.5 mg/ml puromycin (Sigma).
Similarly, to generate stable K8 wild type and phospho-mutants
overexpressed clones, 2 mg of plasmid DNAs were transfected into
the K8-knockdown cells. The cells were selected (second selection)
in 1000 mg/ml G418 sulphate containing medium. Single cell
clones were isolated, expanded and screened for the overexpres-
sion of K8 wild type and phospho-mutants using laser confocal
microscopy, RT-PCR and western blot analysis.
Western blot analysis
Whole cell lysates were prepared in SDS lysis buffer (2% SDS,
50 mM Tris-HCl pH 6.8, 0.1% BME and 10% glycerol) with
protease inhibitors cocktail (Calbiochem). Equal amount of protein
was loaded and run on SDS-PAGE. The gels were transferred on
PVDF membrane (Hybond Amersham) and probed with the
primary antibody followed by secondary antibody conjugated with
HRP (Amersham). The primary antibodies used were as follows:
K8 (Sigma; working dilution 1:8000), K18 (Sigma; dilution
1:8000), GFP (Clonetech; dilution 1:8000), Keratin8-pSer73
(LifeSpan Biosciences; dilution 1:1000), Keratin8-pSer431 (Ab-
cam; dilution 1:1000) and b-actin (Sigma; dilution 1:8000). The
signals were detected using ECLplus detection system (Amersham)
according to manufacturer’s protocol.
Immunofluorescence and laser confocal microscopy
To detect the localization of proteins and filament organization
of keratins in cells, immunofluorescence assay was performed as
described previously [45]. Briefly, the cells were grown on glass
cover slips for 48 hrs and were fixed with 100% chilled methanol.
After fixation, coverslips were washed with 1X PBS and then
permeabilized using 0.3% Triton X-100 in methanol. After
permeabilization, the cells were blocked with 5% BSA for 1 hr.
The cells were then layered with 50 ml of 1:200 diluted K18
antibody and incubated for 1 hr. The coverslips were washed with
1XPBS followed by incubation with 50 ml of 1:200 diluted Alexa-
Fluor-568-conjugated anti-mouse-IgG secondary antibody (Mo-
lecular probes) for 1 hr. Coverslips were then washed and
mounted using antiquenching agent and confocal images were
obtained using a LSM 510 Meta Carl Zeiss Confocal system.
RNA isolation and reverse transcriptase-polymerase chain
reaction (RT-PCR)
RNA was isolated by TRI reagent (Sigma) and RT-PCR was
conducted using RevertAid
TM First Strand cDNA synthesis Kit
(Fermentas) according to manufacturer’s protocol. The following
primers were used, Keratin 8-forward 59-AGATGAACCGGAA-
CATCAGC-39, reverse 59-AGCAGCTTCCTGTAGGT- 39 and
GAPDH forward 59-GAAGGTGAAGGTCGGAGTC-39 reverse
59-GAAGATGGTGATGGGATTTC-39. PCR conditions were
as follows: denaturation at 94uC for 30 s annealing at 56uC and
58uC for Keratin 8 and GAPDH respectively for 30 s and extension
at 72uC for 60 s. PCR products were run on agarose gel
electrophoresis to compare RNA levels.
Fluorescence microscopy analysis and wound-healing
assay for cell motility
To check the effect of loss of K8 phosphorylation on cell
motility, differential distribution of K8 phospho-mutants and wild
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microscopy. The cells were seeded in 35 mm tissue culture plates
in selection medium and allowed to grow for 48 hrs. The GFP
expression was analyzed and images of 5 different fields of the
clones were taken using an AxioCam MRm camera. Wound-
healing assay was performed as described previously. Briefly, the
cells were grown in 35 mm plates to 95% confluency and were
replaced with fresh medium containing 20 mg/ml mitomycin C to
inhibit cell proliferation. After 3 hr incubation, medium was
discarded and wounds were scratched with the help of sterile 2 ml
pipette tip. The cells were fed with fresh medium and observed by
time lapse microscopy, and images were taken every 109 for 20 hr.
Migration was measured using Axiovision software version 4.5
(Zeiss).
Tumor formation in NOD-SCID mice
To test the tumorigenicity of the cells the NOD-SCID mice (6–8
weeks old) were used. AW13516 clones (both K8 wild type and
phospho-mutants overexpressed cells) were suspended in plane
IMDM without serum, 3610
6 cells were injected sub-cutaneously
in the dorsal flank of 6–8 weeks old NOD-SCID mice. Six mice
were injected for each clone and observed for 60 days for tumor
formation. The ellipsoid volume formula 1/2 x L x W x H was
used to calculate the tumor volume [14].
Surgical specimens and clinico-pathological records of
the patients
Tumor tissues were collected from the Tata Memorial Hospital
(TMH), Parel, Mumbai, India. A total of 52 K8 positive primary
oral SCC (34 SCC of tongue and 18 SCC of buccal mucosa) were
selected for IHC analysis. Five punch biopsy samples of patients
suffering from inflammatory fibrous hyperplasia of oral cavity (2
BM and 3 Gingival) were obtained from Nair Dental College,
Mumbai, India. The patients had no history of malignancy. These
tissues were used as controls. Clinico-pathological information like
tumor site, size, histological grade, perineural invasion, perineural
extension, cut margins, bone and lymph node involvement, loco-
regional recurrence, metastasis and survival was collected from the
clinical and pathology records of Tata memorial Hospital
(supplementary material; Table S1).
Histology and immunohistochemistry (IHC)
Tissue samples were fixed in 10% formalin buffer and five
micron sections were cut from paraffin embedded blocks. Sections
were stained with hematoxylin and eosin (H&E) for histological
diagnosis. Immunohistochemical staining was performed using
Elite ABC Kit (Vector laboratories; USA) as described earlier [45].
The primary antibodies used were against K8 (dilution 1:200),
phosphorylated Ser73 of K8 (dilution 1:100) and phosphorylated
Ser431 of K8 (dilution 1:200). The negative control was kept with
tris-buffered saline instead of primary antibody. Specimens were
divided into following categories 1. For K8, High (homogenous
positive tumor in more than 50% of cells or/and high
membranous and cytoplasmic staining in more than 50% of cells;
++/+++) and low (20–50% positive tumor cells; +) 2. For
phosphorylated K8-Ser73 and Ser431, positive (homogenous
positive tumor in more than 20% of cells or/and high
membranous and cytoplasmic staining in more than 20% of cells;
+/++/+++) and negative (less than 20% positive cells or no
evidence of staining; 2). Results of IHC were independently
assessed by two observers.
Statistical analysis
To assess correlations between clinico-pathological parameters
and results of IHC, the Chi Square test was used. Univariant
analysis was performed using the Kaplan-Meier method and
statistical significance between survival curves was assessed by the
log rank tests. The data were analyzed with the Statistical Package,
SPSS 16.0 for Windows (SPSS Inc., Chicago, IL, USA). Two
groups of data were statistically analyzed by t test using Graphpad
Prism5 software. A P value less than 0.05 was considered
statistically significant.
Supporting Information
Figure S1 IHC analysis of K8 expression in malignant
and non-malignant human oral tissues. Representative
images of H&E and IHC staining using antibody against K8 on
paraffin embedded sections of human oral tumors and non-
malignant tissues. Note that non-malignant oral tissues showed
negative staining while malignant tissues showed positive staining
of K8.
(TIF)
Figure S2 IHC staining of phosphorylated K8 in human
OSCC. Representative images of H&E staining along with
positive IHC staining with antibodies specific to phosphorylated
Ser73 and Ser431 of K8 on paraffin embedded sections of human
OSCC.
(TIF)
Table S1 Clinico-pathological parameters of OSCC
patients (n=52).
(DOC)
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